The global dialysis market size was estimated to be USD 100.92 billion in 2023 and is expected to reach at USD 209.60 billion by 2034 with a CAGR of 6.87% during the forecast period 2024-2034. An increasing demand for the treatment of renal therapy at clinics by patients, growing trend among individuals to receive care in the comfort of their homes, rising efforts to prevent & control renal illnesses, increasing regulatory approvals of new products & consumables, surge in prevalence of chronic kidney diseases such as end-stage renal disease, increasing number of highly qualified nephrologists, and rising introduction of cutting-edge dialysis systems are the factors propelling the market growth.
Rising introduction of innovative dialysis systems is predicted to boost the market growth during the forecast period. Dialysis is a therapeutic procedure employed to remove waste products like urea and creatinine from the blood, addressing impaired kidney function, and is commonly prescribed for individuals with chronic renal failure. Those diagnosed with End-Stage Renal Disease (ESRD) typically undergo dialysis treatment at renal facilities. A number of studies have demonstrated a beneficial effect on hemodialysis patients' death rates, which has led to the expected rise in the use of these systems. For instance, in March 2022, NIPRO has officially launched its SURDIAL DX Hemodialysis System in the United States. This device has been designed to incorporate patient-focused features, aiming for optimal performance, efficiency, and ergonomics.
By type, services was the highest revenue-grossing segment in the global dialysis market in 2023 owing to the rise of well-equipped renal care facilities, catering to both chronic & acute care, is coupled with an increasing burden of kidney diseases. Additionally, products is predicted to grow at fastest CAGR during the forecast period owing to the growing number of local & regional market players are emerging to meet the increasing demand for advanced products & consumables. For instance, in April 2022, The U.S. Food and Drug Administration (FDA) has granted approval under 510(k) rules for Versi Peritoneal Dialysis (PD) Cycler System by Fresenius Medical Care North America. This system is a portable automated peritoneal dialysis system.
By dialysis, hemodialysis was the highest revenue-grossing segment in the global dialysis market in 2023 owing to the clinical benefits associated with hemodialysis, such as shorter duration & the adoption of arteriovenous (AV) fistula, rising incidence of severe chronic kidney disease (CKD) among the geriatric population, and growing regulatory approvals. For instance, in November 2022, Fresenius Medical Care North America has announced FDA clearance for its AquaA Water Purification System designed for hemodialysis. Additionally, peritoneal dialysis is predicted to grow at fastest CAGR during the forecast period owing to the growing preference for peritoneal dialysis over hemodialysis and rising demand for at-home peritoneal dialysis treatment.
By end-user, dialysis center & hospital was the highest revenue-grossing segment in the global dialysis market in 2023 owing to the increasing provision of favorable reimbursements by renal facilities & hospitals for renal therapies, growing number of patients afflicted with chronic kidney disease (CKD) & end-stage renal disease (ESRD), rising healthcare expenditure by the population, growth in the number of patients served by dialysis centers, and surge in mergers & acquisitions within market players. For instance, in May 2023, The purchase of Fresenius Medical Care's renal dialysis clinic operations in Southern Africa has been announced by Life Healthcare. Additionally, home care is predicted to grow at fastest CAGR during the forecast period owing to the affordability of homecare dialysis as a treatment for end-stage kidney disease (ESKD) and growing launch of next-generation products for home dialysis.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in prevalence of CKD & ESRD, increasing demand for dialysis services & products, rising geriatric population suffering from renal disorders, and growing launch of innovative dialysis systems. for instance, in November 2023, Diality Inc. has announced plans to introduce its Moda-flx Hemodialysis System at ASN Kidney Week 2023, taking place from November 1 to 5 at the Pennsylvania Convention Center in Philadelphia. Additionally, Asia Pacific region is anticipated to grow at fastest CAGR during the forecast period owing to the escalating accessibility of dialysis services, rising spending to make renal care more accessible by leading market players, and surge in collaboration among market players for the introduction of innovative technologies. For instance, in June 2023, NephroPlus, an Indian dialysis service provider, has introduced an innovative Container Dialysis Unit in collaboration with Shri Vamshi Hospital. This initiative is designed to offer real-time monitoring, consultations, and other related services to dialysis patients.
Rising introduction of innovative dialysis systems is predicted to boost the market growth during the forecast period. Dialysis is a therapeutic procedure employed to remove waste products like urea and creatinine from the blood, addressing impaired kidney function, and is commonly prescribed for individuals with chronic renal failure. Those diagnosed with End-Stage Renal Disease (ESRD) typically undergo dialysis treatment at renal facilities. A number of studies have demonstrated a beneficial effect on hemodialysis patients' death rates, which has led to the expected rise in the use of these systems. For instance, in March 2022, NIPRO has officially launched its SURDIAL DX Hemodialysis System in the United States. This device has been designed to incorporate patient-focused features, aiming for optimal performance, efficiency, and ergonomics.
By type, services was the highest revenue-grossing segment in the global dialysis market in 2023 owing to the rise of well-equipped renal care facilities, catering to both chronic & acute care, is coupled with an increasing burden of kidney diseases. Additionally, products is predicted to grow at fastest CAGR during the forecast period owing to the growing number of local & regional market players are emerging to meet the increasing demand for advanced products & consumables. For instance, in April 2022, The U.S. Food and Drug Administration (FDA) has granted approval under 510(k) rules for Versi Peritoneal Dialysis (PD) Cycler System by Fresenius Medical Care North America. This system is a portable automated peritoneal dialysis system.
By dialysis, hemodialysis was the highest revenue-grossing segment in the global dialysis market in 2023 owing to the clinical benefits associated with hemodialysis, such as shorter duration & the adoption of arteriovenous (AV) fistula, rising incidence of severe chronic kidney disease (CKD) among the geriatric population, and growing regulatory approvals. For instance, in November 2022, Fresenius Medical Care North America has announced FDA clearance for its AquaA Water Purification System designed for hemodialysis. Additionally, peritoneal dialysis is predicted to grow at fastest CAGR during the forecast period owing to the growing preference for peritoneal dialysis over hemodialysis and rising demand for at-home peritoneal dialysis treatment.
By end-user, dialysis center & hospital was the highest revenue-grossing segment in the global dialysis market in 2023 owing to the increasing provision of favorable reimbursements by renal facilities & hospitals for renal therapies, growing number of patients afflicted with chronic kidney disease (CKD) & end-stage renal disease (ESRD), rising healthcare expenditure by the population, growth in the number of patients served by dialysis centers, and surge in mergers & acquisitions within market players. For instance, in May 2023, The purchase of Fresenius Medical Care's renal dialysis clinic operations in Southern Africa has been announced by Life Healthcare. Additionally, home care is predicted to grow at fastest CAGR during the forecast period owing to the affordability of homecare dialysis as a treatment for end-stage kidney disease (ESKD) and growing launch of next-generation products for home dialysis.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in prevalence of CKD & ESRD, increasing demand for dialysis services & products, rising geriatric population suffering from renal disorders, and growing launch of innovative dialysis systems. for instance, in November 2023, Diality Inc. has announced plans to introduce its Moda-flx Hemodialysis System at ASN Kidney Week 2023, taking place from November 1 to 5 at the Pennsylvania Convention Center in Philadelphia. Additionally, Asia Pacific region is anticipated to grow at fastest CAGR during the forecast period owing to the escalating accessibility of dialysis services, rising spending to make renal care more accessible by leading market players, and surge in collaboration among market players for the introduction of innovative technologies. For instance, in June 2023, NephroPlus, an Indian dialysis service provider, has introduced an innovative Container Dialysis Unit in collaboration with Shri Vamshi Hospital. This initiative is designed to offer real-time monitoring, consultations, and other related services to dialysis patients.
Segmentation: Dialysis Market Report 2023 - 2034
Dialysis Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Services
- Products
Dialysis Market Analysis & Forecast by Dialysis 2023 - 2034 (Revenue USD Bn)
- Peritoneal Dialysis
- Hemodialysis
Dialysis Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Home Care
- Dialysis Centers & Hospitals
Dialysis Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Dialysis Market: Type Estimates & Trend Analysis
8. Dialysis Market: Dialysis Estimates & Trend Analysis
9. Dialysis Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Dialysis Market
12. Europe Global Dialysis Market
13. Asia Pacific Global Dialysis Market
14. Latin America Global Dialysis Market
15. MEA Global Dialysis Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Baxter International Inc.
- Nipro Corporation
- Diaverum Deutschland Gmbh
- Davita
- Angiodynamics Inc.
- Asahi Kasei Corporation
- B. Braun Melsungen Ag
- Medtronic
- Fresenius Se and Co. Kgaa
- Nikkiso Co. Ltd.
- Becton
- Dickinson And Company
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 100.92 Billion |
| Forecasted Market Value ( USD | $ 209.6 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
